- Home
- LEE vs MIST Comparison
LEE vs MIST Comparison
Compare LEE & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- MIST
- Stock Information
- Founded
- LEE 1890
- MIST 2003
- Country
- LEE United States
- MIST Canada
- Employees
- LEE N/A
- MIST N/A
- Industry
- LEE Newspapers/Magazines
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- LEE Consumer Discretionary
- MIST Health Care
- Exchange
- LEE Nasdaq
- MIST Nasdaq
- Market Cap
- LEE 38.2M
- MIST 89.8M
- IPO Year
- LEE N/A
- MIST N/A
- Fundamental
- Price
- LEE $6.32
- MIST $1.92
- Analyst Decision
- LEE
- MIST Strong Buy
- Analyst Count
- LEE 0
- MIST 2
- Target Price
- LEE N/A
- MIST $7.50
- AVG Volume (30 Days)
- LEE 36.5K
- MIST 613.1K
- Earning Date
- LEE 07-31-2025
- MIST 08-07-2025
- Dividend Yield
- LEE N/A
- MIST N/A
- EPS Growth
- LEE N/A
- MIST N/A
- EPS
- LEE N/A
- MIST N/A
- Revenue
- LEE $591,094,000.00
- MIST N/A
- Revenue This Year
- LEE N/A
- MIST N/A
- Revenue Next Year
- LEE N/A
- MIST N/A
- P/E Ratio
- LEE N/A
- MIST N/A
- Revenue Growth
- LEE N/A
- MIST N/A
- 52 Week Low
- LEE $5.83
- MIST $0.63
- 52 Week High
- LEE $19.63
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- LEE 47.62
- MIST 67.01
- Support Level
- LEE $5.83
- MIST $1.85
- Resistance Level
- LEE $6.72
- MIST $2.02
- Average True Range (ATR)
- LEE 0.38
- MIST 0.09
- MACD
- LEE 0.07
- MIST 0.01
- Stochastic Oscillator
- LEE 71.37
- MIST 73.75
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).